May 13 · 14 min
Science
CME in Minutes: Education in Oncology & Hematology
Answers in CME
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Oncology & Hematology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for oncologists and hematologists to cover the diagnosis, staging, treatment, follow-up, and clinical management of tumors and hematological malignancies. Earning your CME/CE credits has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.
- 148 episodes
- Updated Friday
Episodes148
- May 12 · 16 min
Sebastien J. Hotte, MD, FRCPC - An Integrated Approach to Optimizing Radioligand Therapy and Bone Health Management in mCRPC
- May 8 · 36 min
30-Minute Power Briefing: ICIs in Frontline Advanced Classical Hodgkin Lymphoma—What’s New and What’s Now?
- May 5 · 14 min
From Burden to Breakthrough: The Rise of KIT D816V-Selective Therapy in Indolent Systemic Mastocytosis
- April 30 · 26 min
Guidance on Menopause-Related Vasomotor Symptom Management: A Focus on Neurokinin-Targeted Treatment Options
- April 27 · 1 hr 3 min
From Evidence to Practice: Where Do BCMA Bispecific Antibodies and Anti-CD38 mAb Combinations Fit Into Community Care for RRMM?
- April 24 · 19 min
Evolving Care in B-ALL: From Questions to Answers on the Role of CD19 Bispecific T-Cell Engagers
- April 23 · 1 hr 10 min
Navigating Urologic Cancer Care Across the Map: Getting up to Speed on the Latest Systemic Therapies for Renal Cell Carcinoma and Advanced Urothelial Carcinoma
- April 20 · 1 hr 1 min
Management of High-Risk CLL in the BTK Inhibitor Era: Frontline to Double-Refractory Disease
- April 17 · 1 hr 11 min
Navigating Urologic Cancer Care Across the Map: Getting up to Speed on the Latest Systemic Therapies for Renal Cell Carcinoma and Advanced Urothelial Carcinoma
- April 15 · 12 min
The ON Switch: Overcoming KRAS Resistance Using Next-Generation Targeted Inhibitors in Advanced NSCLC
- April 10 · 15 min
The Next Wave of CAR T Innovation for RRMM: Insights Into Emerging GPRC5D-Directed CAR T-Cell Therapies
- April 10 · 1 hr 10 min
Navigating Urologic Cancer Care Across the Map: Getting up to Speed on the Latest Systemic Therapies for Renal Cell Carcinoma and Advanced Urothelial Carcinoma
- April 8 · 25 min
Bridging Clinic and OR: A Dialogue on the Emerging Role of Neoadjuvant HER2-Directed ADCs in HER2+ Breast Cancer
- April 1 · 30 min
Survivorship Strategies for Patients on First-Line HER2+ mBC Maintenance Therapies: Practical Guidance on Monitoring and AE Management
- March 24 · 15 min
When Form Maximizes Function: Examining the Role of Subcutaneous Immune Checkpoint Inhibitors in Oncology Practice
- March 20 · 1 hr 8 min
HER2 in Focus: Guiding Bladder Cancer Treatment Personalization in the Era of Antibody-Drug Conjugates
- March 20 · 26 min
Contextualizing the Data for Novel First-Line HER2+ mBC Maintenance Therapies: How Might the Treatment Paradigm Change?
- March 18 · 16 min
Bridging Evidence and Practice: Updates on HER2-Targeted ADCs for Gastric/GEJ Adenocarcinoma
- March 13 · 24 min
Facing Therapeutic Resistance to Maintenance Therapy: The Need for Novel Strategies in HER2+ mBC